Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

Multiple myeloma (MM), which is caused by ... can insert into the cell membrane and inhibit activation of AKT1, leading to myeloma cell death 10. Perifosine might also augment the impact of ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Despite these challenges, advances in the field are improving the outlook for people diagnosed with multiple myeloma. As evidence, the five-year overall survival rate in the United States has ...

Accurate information has emerged regarding the cause of death of John Kumah ... It has been confirmed that Kumah succumbed to Multiple Myeloma, a medical condition that he had been battling ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...